` VLS (Vita Life Sciences Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

VLS
vs
S&P/ASX 300

Over the past 12 months, VLS has underperformed S&P/ASX 300, delivering a return of -15% compared to the S&P/ASX 300's 6% growth.

Stocks Performance
VLS vs S&P/ASX 300

Loading

Performance Gap
VLS vs S&P/ASX 300

Loading
VLS
S&P/ASX 300
Difference

Performance By Year
VLS vs S&P/ASX 300

Loading
VLS
S&P/ASX 300
Add Stock

Competitors Performance
Vita Life Sciences Ltd vs Peers

S&P/ASX 300
VLS
LLY
JNJ
NOVO B
ROG
Add Stock

Vita Life Sciences Ltd
Glance View

Market Cap
104.6m AUD
Industry
Pharmaceuticals

Vita Life Sciences Ltd. engages in the formulation, packaging, sale and distribution of vitamins and supplements. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-08-23. The firm is involved in the formulating, packaging, sales and distributing vitamins and supplements. The Company’s core business is the development and distribution of over the counter (OTC) medicines, as well as complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, Malaysia, Singapore, Thailand, Vietnam, China and Indonesia. The company offers products under the brands, such as Herbs of Gold, VitaHealth, VitaScience and VitaLife. The firm operates in Australia, Singapore, Malaysia and others. The firm subsidiaries include Tetley Research Pty Limited, Tetley Treadmills Pty Limited, Tetley Manufacturing Pty Limited, Vimed Bio Sciences Pty Limited, Allrad No 19 Pty Limited, Lovin Pharma International Limited, Herbs of Gold Pty Limited, VitaHealth Laboratories Australia Pty Limited and Vita Institute of Health Pty Ltd.

VLS Intrinsic Value
2.41 AUD
Undervaluation 23%
Intrinsic Value
Price
Back to Top